<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
TRVI
Trevi Therapeutics
$
()


  • Trevi Therapeutics reports Q4 EPS (8c), consensus (9c)

    3/20/2024 - 16:07pm
  • Biotech Alert: Searches spiking for these stocks today

    2/22/2024 - 10:59am
  • Trevi Therapeutics initiates Phase 2b CORAL clinical trial of Haduvio in IPF

    12/5/2023 - 07:33am
  • Trevi Therapeutics reports Q3 EPS (8c), consensus (9c)

    11/9/2023 - 16:23pm
  • Trevi Therapeutics initiates Phase 2a RIVER clinical trial of Haduvio

    11/2/2023 - 08:27am
  • Trevi Therapeutics announces 52-week results from Phase 2b/3 PRISM study

    10/13/2023 - 08:35am
  • Trevi Therapeutics reports Q 2EPS (7c), consensus (8c)

    8/10/2023 - 16:09pm
  • Trevi Therapeutics files $200M mixed securities shelf

    6/29/2023 - 17:08pm
  • Trevi Therapeutics management to meet with Oppenheimer

    6/5/2023 - 04:55am
  • Trevi Therapeutics management to meet with Oppenheimer

    5/31/2023 - 07:47am
  • Trevi Therapeutics announces results from Phase 2 CANAL trial

    5/22/2023 - 16:08pm
  • Trevi Therapeutics management to meet with B. Riley

    5/22/2023 - 04:55am
  • Trevi Therapeutics management to meet with Oppenheimer

    5/18/2023 - 04:55am
  • Trevi Therapeutics management to meet with B. Riley

    5/15/2023 - 11:50am
  • Trevi Therapeutics management to meet with Oppenheimer

    5/15/2023 - 11:49am
dynamic_feed Breaking News